MétaCan
Menu
Back to cohort
Record W4362505861 · doi:10.1093/jtm/taad042

Correspondence letter regarding ‘Is standby therapy for Covid-19 a practical option for travellers?’

2023· letter· en· W4362505861 on OpenAlexaffabout
Michael Libman

Bibliographic record

VenueJournal of Travel Medicine · 2023
Typeletter
Languageen
FieldMedicine
TopicTravel-related health issues
Canadian institutionsMcGill University
Fundersnot available
KeywordsMedicineCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakLibrary scienceFamily medicineGerontologyInternal medicineVirologyInfectious disease (medical specialty)Outbreak

Abstract

fetched live from OpenAlex

I have read with interest the perspective piece by Chen and Connor1 regarding the use of standby therapy for COVID-19 amongst travellers. Vaccination, including regular booster doses, will certainly remain the principal preventive measure to mitigate the risk of serious COVID-19 illness and complications amongst international travellers for the foreseeable future.2 Nevertheless, recent guidelines published by the Canadian Committee to Advise on Tropical Medicine and Travel for the Public Health Agency of Canada (available at https://www.canada.ca/en/public-health/services/catmat/statement-covid-19-international-travel.html) also recommend provision of standby treatment in certain cases. Rapid testing kits are widely available, and offered for free or low cost in many jurisdictions. There is widespread familiarity with their use, although testing proficiency amongst the general public has not been well studied. Informal surveys by colleagues confirm that nirmatrelvir–ritonavir remains difficult to obtain in many countries. In Canada, and perhaps elsewhere, there remains a problem with legal prescription of this medication for this indication. Although there appear to be no issues related to sufficient supply, distribution of nirmatrelvir–ritonavir remains under the control of provincial governments, using a federal government stockpile, rather than the usual wholesale pharmaceutical system. Provincial criteria for distribution by pharmacies include the need for a positive test for SARS-CoV-2, and there are currently no provisions for retail sales outside the government system. In other words, even for someone willing to pay for their prescription, which costs hundreds of dollars per course when purchased by governments, the medication remains unavailable to travellers who are not currently infected. Travel medicine providers should consider lobbying their local regulatory authorities, as well as insurance agencies, to raise awareness of this paradoxical situation. The author had no financial support for this manuscript. The author is the chair of the Committee to Advise on Tropical Medicine and Travel for the Public Health Agency of Canada. However, this correspondence represents his personal opinion alone, and does not represent the position of the Public Health Agency of Canada or Health Canada.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.014
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Commentary · Consensus signal: Commentary
Teacher disagreement score0.042
Threshold uncertainty score0.140

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.014
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0010.000
Science and technology studies0.0030.001
Scholarly communication0.0020.002
Open science0.0010.001
Research integrity0.0150.013
Insufficient payload (model declined to judge)0.0420.020

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.212
GPT teacher head0.459
Teacher spread0.248 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreCommentary

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2023
Admission routes2
Has abstractyes

Explore more

Same venueJournal of Travel MedicineSame topicTravel-related health issuesFrench-language works237,207